John-Anthony Salvaggio

Senior Sales Representative at Supernus Pharmaceuticals Inc

John-Anthony Salvaggio's Professional Contact Details

Email (Verified)

****@supernus.com

Get Email Address

(301) 838-2500

Location

New York, New York, US

Company

Supernus Pharmaceuticals Inc

Person Seniority

senior

Person Functions

sales

John-Anthony Salvaggio's Current Company Details

Supernus Pharmaceuticals Inc

Rockville, Maryland, US • 337 Employees

pharmaceuticals

Pioneering New Medicines in Neurology and Psychiatry With more than 20 years of experience, we are a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) disorders. In 2013 we launched Oxtellar XRÂ® and Trokendi XRÂ®, two novel neurology products for the treatment of epilepsy. We are also developing several product candidates in psychiatry to address unmet medical needs and opportunities in attention-deficit hyperactivity disorder (ADHD) and its coexisting disorders, and depression. We are developing differentiated products by leveraging our proprietary and in-licensed technologies. We use such technologies to discover and develop novel uses for known drug compounds and to enhance their therapeutic benefits. Our focus on known drug compounds with established mechanisms of action reduces the risks, costs, and time typically associated with pharmaceutical product development.

Public Symbol

SUPN

Founded Year

2005

Organization Website

supernus.com

Organization Languages

English

Organization Revenue

215000

Current Technologies

rackspace mailgun